Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

In recent months, the society around the globe has been going through a process of change of deceleration and standstill. Priorities have been redefined and implemented at record speeds in many places. Covid-19 serves as a catalyst for change for many people. The reasons can b...
Mario Hose | July 15, 2020 |

Gilead, Teva, XPhyto - Global marketing potential

The best business models solve problems and are scalable. In this context, the healthcare sector is particularly interesting. The world's population has recently reached 7.8 billion people and for this reason solutions can meet a large potential market with users. Cross-border...
Mario Hose | June 16, 2020 |

Warren Buffett and everything else versus gold

Below is an excerpt from a commentary originally posted at www.speculative-investor.com on June 14, 2012. We discussed Warren Buffett's illogical opinions about gold in our February 15, 2012, report under the heading "Buffett's Blind Spot." Today we are goi...
Steven Saville | October 28, 2012 |

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

Tuesday began with green lights for most listed companies in Germany. The opinions of analysts and company announcements make the stock prices - or they are driven by the mood of economic data. The Ifo Business Climate Index, for example, rose by 2.2 points to 92.6 points in...
Mario Hose | August 25, 2020 |

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Experienced investors assume that the DAX, Germany's leading index, will still reach new highs in 2020. One of the best-known supporters of this scenario is the asset manager Dr. Jens Ehrhardt. Rising markets are supported by the measures taken by central banks and politicians...
Mario Hose | June 18, 2020 |

Our Fib Trading System is Telling Us Where The Market Is Headed Next

In this section of our multi-part research post centered around our Adaptive Fibonacci Price Modeling system’s expectations, we are focusing on the NQ (NASDAQ futures) and the future expected price rotations. As we discussed earlier, in Part I , Fibonacc...
Chris Vermeulen | April 9, 2020 |

Buzz on the Bullboards: PyroGenesis, Antibe Top All Sectors

The reign of COVID-19 related gains is over on the Stockhouse Bullboards. Instead, the new king comes from the unlikeliest of sectors: Industrials. Of course, it’s not surprising to have a profitable and quickly rising small-cap company in the industrials s...
Omri Wallach | June 17, 2020 |

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the...
Mario Hose | July 29, 2020 |

Buzz on the Bullboards: Eyes on Cannabis Rebound

For the first week since March, COVID-19 related plays didn’t top the Stockhouse Bullboards. Instead, that spot was reclaimed by a resurgent cannabis sector. Last week saw a string of strong quarterly releases from major LP’s is something t...
Omri Wallach | May 20, 2020 |

NexTech AR Solutions Update After Major Ramp-Up

Technical analyst Clive Maund provides an update on the prospects for this technology firm. While clivemaund.com is primarily a resource stocks website, we recognize that investing is an opportunity cost game, and for this reason we have no problem buying a tech stock...
Streetwise Reports | November 26, 2019 |
1 2 3 4 5 6 7 8 9 10 ...